TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521). [electronic resource]
Producer: 20150813Description: 67-73 p. digitalISSN:- 1523-6536
- Adolescent
- Adrenal Cortex Hormones -- therapeutic use
- Bronchoalveolar Lavage Fluid -- chemistry
- Child
- Child, Preschool
- Cytokines -- biosynthesis
- Drug Therapy, Combination
- Etanercept
- Female
- Hematologic Neoplasms -- immunology
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Idiopathic Interstitial Pneumonias -- etiology
- Immunoglobulin G -- therapeutic use
- Immunosuppressive Agents -- therapeutic use
- Infant
- Male
- Receptors, Tumor Necrosis Factor -- antagonists & inhibitors
- Respiration, Artificial
- Siblings
- Survival Analysis
- Transplantation, Homologous
- Treatment Outcome
- Unrelated Donors
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.